Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.

Eli Lilly said Wednesday it will invest $27 billion to build four new manufacturing plants in the United States as the pharmaceutical giant grapples with the threat of drug import duties from the ...

Eli Lilly, a pharmaceutical company, employs more than 12.000 people in Indianapolis and more than 42,000 worldwide © 2025 Fortune Media IP Limited. All Rights ...

All told, Eli Lilly has tallied up about $23 billion in U.S. manufacturing commitments in recent years. The new pledge represents about $27 billion in additional planned spending. Related ...

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a deal worth up to $50 million in biobucks. Organovo’s stock ...

A major pharmaceutical company that has invested heavily in North Carolina is planning multiple new factories in the U.S. STORY HIGHLIGHTS Eli Lilly plans $27 billion U.S. expansion, will create ...

Eli Lilly and Company has announced a historic $50bn investment to expand its US manufacturing footprint, marking the largest investment of its kind in the pharmaceutical industry's history. The ...

Eli Lilly is unleashing new ammunition in its ... programs do not systematically cover people living with obesity for medical care" in the U.S. "Lilly is committed to working with all parties ...

Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that's the case with Eli Lilly drug Zettbound. Federal judge rules Trump administration has ...

If a traditional CPAP machine isn't for you, you might consider the Inspire sleep apnea device as an alternative ... so there are some medical bills that will have to be taken into account.

It is now available—with a beta label—as part of iOS 18.3, macOS Sequoia 15.3, and iPadOS 18.3. Here is the full list of devices that support Apple Intelligence. The first steps of an upgraded ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults ...